Home > Press > Los Alamos National Laboratory Collaboration with Russian Scientists Yields Marketable Nano-Titanium Technology
Abstract:
Airplanes and Cars Go On a Nanotechnology Diet
Manhattan Scientifics (Pink Sheets:MHTX) announced today that immediately after its recent acquisition of Metallicum Inc., the company began manufacturing and seeking licensing partners for NanoTitanium, its proprietary new form of nanostructured metal developed by scientists at Los Alamos National Laboratory in conjunction with colleagues in Russia. The company also began pursuing strategic corporate partners in the auto, truck, rail, aircraft manufacturing and medical industries.
Manhattan Scientifics' acquisition of Metallicum Inc. was an important step towards formulating its new business plan, positioning itself as a "green" technology development company. On July 2, 2008 U.S. Senator Jeff Bingaman led a news conference describing Manhattan Scientifics' positive potential impact on New Mexico and the U.S.
The use of super stronger metals means less material is required for the same purpose, translating to lighter weight and reduced environmental impact. The proprietary technology is expected to trim thousands of pounds from airplanes and hundreds of pounds from cars without sacrificing structural strength or adding significant cost. The fuel savings to the American public could be significant. A New York Times article on June 11 titled To Save Fuel, Airlines Find No Speck Too Small further details how airlines are scrutinizing every step of their operations, searching for new ways to cut fuel bills.
The company's nanostructured metals also have wide implications for use in the medical device and prosthetics industries including cardiovascular stents, dental implants, and replacements for hips, shoulders and knees. Clinical studies have shown that bone integrates with these new metals up to 20 times faster than with conventional metals. This means faster healing after surgery and ultimately longer lifetime for nanostructured metal implants.
Recently, Manhattan Scientifics recruited new management, raised $1.75 million of capital, purchased and cancelled 43 million of its own shares, and dedicated itself to growth by acquisition.
####
About Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc., www.mhtx.com, is located in New Mexico, New York, and Montreal. It is developing and plans to acquire technologies in a variety of environmentally friendly energy and other people-friendly industries. Copies of Manhattan Scientifics' press releases and related investor information may also befound at www.hawkassociates.com.
For more information, please click here
Contacts:
Executive Contacts:
Los Alamos National Labs - Kevin Roark
Phone: 505-665-9202
Manny Tsoupanarias
Phone: 918-919-0370
Metallicum, Inc. - Dr. Terry Lowe
Phone: 505-670-8755
For Investor Relations contact MHTX Chairman Emeritus Marvin Maslow
Phone: 917-923-3300
Copyright © Manhattan Scientifics, Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Laboratories
A battery’s hopping ions remember where they’ve been: Seen in atomic detail, the seemingly smooth flow of ions through a battery’s electrolyte is surprisingly complicated February 16th, 2024
NRL discovers two-dimensional waveguides February 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Automotive/Transportation
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
Aerospace/Space
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Under pressure - space exploration in our time: Advancing space exploration through diverse collaborations and ethical policies February 16th, 2024
Bridging light and electrons January 12th, 2024
Alliances/Trade associations/Partnerships/Distributorships
Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022
University of Illinois Chicago joins Brookhaven Lab's Quantum Center June 10th, 2022
Research partnerships
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Researchers’ approach may protect quantum computers from attacks March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||